Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Humalog (insulin lispro) - Important Safety Information from Eli Lilly and Co (Ireland) Limited as approved by the HPRA
Notice type:
3rd Party Publications
Date:
16/08/2016
Problem Or Issue:
Important Safety Information communication from Eli Lilly and Co (Ireland) Limited on the correct use of Humalog (insulin lispro) 200 units/ml KwikPen to minimize medication errors.
Important Safety Information - Humalog (insulin lispro)
« Back
Date Printed: 26/04/2024